...
首页> 外文期刊>Molecular cancer therapeutics >Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules.
【24h】

Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules.

机译:抗体-美登木素生物碱偶联物的美登素和细胞代谢产物通过与微管结合而强烈抑制微管动力学。

获取原文
获取原文并翻译 | 示例
           

摘要

Maytansine is a potent microtubule-targeted compound that induces mitotic arrest and kills tumor cells at subnanomolar concentrations. However, its side effects and lack of tumor specificity have prevented successful clinical use. Recently, antibody-conjugated maytansine derivatives have been developed to overcome these drawbacks. Several conjugates show promising early clinical results. We evaluated the effects on microtubule polymerization and dynamic instability of maytansine and two cellular metabolites (S-methyl-DM1 and S-methyl-DM4) of antibody-maytansinoid conjugates that are potent in cells at picomolar levels and that are active in tumor-bearing mice. Although S-methyl-DM1 and S-methyl-DM4 inhibited polymerization more weakly than maytansine, at 100 nmol/L they suppressed dynamic instability more strongly than maytansine (by 84% and 73%, respectively, compared with 45% for maytansine). However, unlike maytansine, S-methyl-DM1 and S-methyl-DM4 induced tubulin aggregates detectable by electron microscopy at concentrations >/=2 mumol/L, with S-methyl-DM4 showing more extensive aggregate formation than S-methyl-DM1. Both maytansine and S-methyl-DM1 bound to tubulin with similar K(D) values (0.86 +/- 0.2 and 0.93 +/- 0.2 mumol/L, respectively). Tritiated S-methyl-DM1 bound to 37 high-affinity sites per microtubule (K(D), 0.1 +/- 0.05 mumol/L). Thus, S-methyl-DM1 binds to high-affinity sites on microtubules 20-fold more strongly than vinblastine. The high-affinity binding is likely at microtubule ends and is responsible for suppression of microtubule dynamic instability. Also, at higher concentrations, S-methyl-DM1 showed low-affinity binding either to a larger number of sites on microtubules or to sedimentable tubulin aggregates. Overall, the maytansine derivatives that result from cellular metabolism of the antibody conjugates are themselves potent microtubule poisons, interacting with microtubules as effectively as or more effectively than the parent molecule.
机译:美登素是一种有效的靶向微管的化合物,可诱导有丝分裂停滞并杀死亚纳摩尔浓度的肿瘤细胞。然而,其副作用和缺乏肿瘤特异性已阻止了成功的临床使用。最近,已开发出抗体缀合的美登素衍生物以克服这些缺点。几种结合物显示出有希望的早期临床结果。我们评估了美登素和抗体-美登木素生物碱偶联物的两种细胞代谢产物(S-甲基-DM1和S-甲基-DM4)对微管聚合和动态不稳定性的影响,这些抗体在皮摩尔水平的细胞中有效并且在荷瘤中活跃老鼠。尽管S-甲基DM1和S-甲基DM4抑制聚合反应的效果比美登素弱,但在100 nmol / L时,它们抑制动态不稳定性的强度比美登素强(分别为84%和73%,而美登素为45%)。但是,与美登素不同的是,S-甲基-DM1和S-甲基-DM4诱导的微管蛋白聚集体可通过电子显微镜在浓度大于等于2摩尔/升的条件下检测到,其中S-甲基-DM4比S-甲基-DM1具有更广泛的聚集体形成。美登素和S-甲基-DM1均以相似的K(D)值(分别为0.86 +/- 0.2和0.93 +/- 0.2μmol/ L)结合到微管蛋白上。 ti化的S-甲基-DM1与每个微管的37个高亲和力位点结合(K(D),0.1 +/- 0.05 mumol / L)。因此,S-甲基-DM1结合微管上的高亲和力位点比长春花碱强20倍。高亲和力结合可能在微管末端,并负责抑制微管动态不稳定性。同样,在较高浓度下,S-甲基-DM1与微管上的大量位点或与可沉淀的微管蛋白聚集体均表现出低亲和力。总的来说,由抗体结合物的细胞代谢产生的美登素衍生物本身就是有效的微管毒物,与亲代分子一样有效或更有效地与微管相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号